A Study to Evaluate the Efficacy and Safety of AD-203

• Status: Completed
• Trial end date: 2020-02-26
• Target enrollment: 0
• Participant gender: All

Summary

This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or chronic gastritis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Addpharma Inc.

Criteria

Inclusion Criteria:

• Age is over 20 years old, under 75 years old, men or women

• Patients diagnosed with acute or chronic gastritis by gastroscopy

Exclusion Criteria:

• Patients who is impossible to receive gastroscopy

• Patients taking other investigational drugs or participating in other clinical studies in 3 months prior to screening visit